CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

ONWARD Medical Publishes Q3 2026 Results Presentation

By Public Technologies
  • ONWARD Medical reported revenue of €2.5 million for the third quarter of 2026.
  • ARCEX systems sold or supplied through paid evaluations totaled 88, up 120% year over year.
  • Net cash stood at €73.4 million on September 30, 2026; quarterly cash burn totaled €8.1 million.
  • Commercial reach exceeded 170 clinics worldwide, including more than 150 US clinics and Veterans Affairs facilities.
  • The Empower BP pivotal trial had enrolled 31 participants, with 16 clinical sites actively recruiting as of November 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ONWARD Medical NV published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk